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2Summary
Ras proteins mediate biological responses through various effectors and play a key role in
relaying the Fibroblast Growth Factor (FGF) mesoderm induction signal during
embryogenesis of the frog, Xenopus laevis. One Ras effector pathway involves the activation
of the small G protein Ral. In the present study, we have investigated the role of key
components in the RalB branch of FGF and Ras signalling during early Xenopus
development. Treatment of animal caps with bFGF, which converts prospective ectoderm  to
mesoderm, activates XralB. The Ras 12V37G mutant, which can bind to Ral-GDS but not
Raf, also activates XralB as well as causing developmental defects and cortical F-actin
disassembly.  A similar phenotype is induced by Ral-GDS itself.  FGF induced expression of
several signature mesodermal genes, by contrast, is independent of XralB signalling.  This
and other data suggest that the RalB branch of Ras and FGF signalling regulates the actin
cytoskeleton and morphogenesis in a transcriptionally-independent manner. We also find
XralB to be specifically activated in the marginal zone of Xenopus embryos, and find that
disruption of the RalB pathway in this region causes gastrulation defects. We conclude that
RalB signalling is autonomously required by mesodermal cells to effect essential
morphogenetic changes during Xenopus gastrulation.
Keywords:  FGF; Ras pathway; RalB; Actin cytoskeleton; gastrulation; Xenopus
3Introduction
Mesoderm induction depends on multiple diffusible extracellular factors that induce
specific programs of gene expression and morphogenesis. Prior to overt gastrulation, a
number of mesoderm-specific transcription factors are transcribed in induced mesoderm (for
reviews (Stennard et al., 1997) and (Chan and Etkin, 2001)). Shortly thereafter, mesodermal
cells participate in stereotyped  gastrulation movements  (for review (Gerhart and Keller,
1986)) that are achieved via coordinated changes in the cytoskeleton of individual cells
(Selchow and Winklbauer, 1997; Wacker et al., 1998). Despite intensive study, the
intracellular signalling pathways connecting mesoderm induction to the direct modification of
the cytoskeleton by effector molecules remain unclear.
FGFs can induce the expression of many mesodermal markers (Kimelman and
Kirschner, 1987), (Green et al., 1992), (Whitman and Melton, 1992) (LaBonne and Whitman,
1994), (Amaya et al., 1991), and expression of a dominant negative FGF receptor
dramatically perturbs gastrulation (Amaya et al., 1991). Mesodermal gene induction by FGFs
has been shown to be achieved via the Ras protein, acting through both the MAPK and PI3K
pathways (Whitman and Melton, 1992), (LaBonne and Whitman, 1994), (Umbhauer et al.,
1995), (Carballada et al., 2001). Ras is also known to modulate the formation of the actin
cytoskeleton in a variety of cell types, but the specific Ras pathway involved is unknown
(Bar-Sagi and Feramisco, 1986). A role for FGF signalling in Drosophila embryonic cell
motility has been found, seen in the requirement  for the FGF receptor heartless molecules for
mesodermal cell migration (Gisselbrecht et al., 1996), (Beiman et al., 1996). More recently,
FGF4 and FGF8 have been shown to control directional movement of streak cells in the chick
(Yang et al., 2002). These data demonstrate that  FGFs are able to control both gene
expression and cellular behavior  (for reviews see (Manske and Bade, 1994), (Montell, 1999),
(Boilly et al., 2000)) and they raise the possibility that during mesoderm development, Ras
4not only mediates the induction of gene expression by FGF signalling, but also controles the
cellular behaviour.
As indicated above, the Ras protein initiates several cellular processes including
proliferation, differentiation and modulation of the cytoskeleton (Reuter and Der, 2000).
Although the Raf serine/threonine kinase is the best-studied Ras effector protein, at least two
other effectors, PI3K (Rodriguez-Viciana et al., 1997) and Ral-GDS (Kikuchi et al.,
1994), are known to mediate Ras signalling. Moreover, a Ras mutant with an inactive effector
domain can be complement by another distinct Ras effector-domain mutant (White et al.,
1995), demonstrating that different Ras effectors can cooperate to transform cells (Urano et
al., 1996).  Recently PI3K was shown to synergize with the extracellular signal regulated
kinase (ERK) pathway in the induction of Xenopus mesoderm (Carballada et al., 2001).
More recently, oncogenic activity was demonstrated for the Ras 12V37G mutant, which binds
and activates Ral-GDS, but not Raf (Hamad et al., 2002).  Much remains to be learned about
the roles of Ras and its various effectors during early development . Of particular interest is
whether or not Ras directly influences cellular morphology via modulation of the
cytoskeleton.
In previous studies, we have characterised XralB, a small G protein of the Ras family,
isolated by differential screening of a subtractive cDNA library (Moreau et al., 1999). This
protein cycles between an inactive GDP-bound and an active GTP-bound conformation. Ral
proteins are activated by the Ras effector, Ral-GDS (Kikuchi et al., 1994)(Wolthuis et al.,
1998b) and have been directly implicated in various cellular mechanisms, such as endocytosis
(Nakashima et al., 1999) and regulation of the actin cytoskeleton (Ohta et al., 1999). By
microinjecting different mutant forms of XralB into Xenopus embryos, we have shown that
expression of an inactivate form of XralB, XralB S28N, blocks gastrulation movements,
whereas a constitutively active form, XralB G23V, causes disruption of the actin cytoskeleton
(Moreau et al., 1999).
5In this paper, we delineate a cascade linking FGF signalling to embryonic
morphogenesis.  We show that exposure of animal caps to bFGF causes activation of XralB,
and that overexpression of an activated  form of XralB causes cortical F-actin disassembly.
We also show that early developmental arrest are caused by ectopic expression of a mutant
form of Ras able to bind  Ral-GDS, but not Raf, or by ectopic expression of Ral-GDS itself.
By contrast, we find that FGF-induced expression of a number of signature mesodermal genes
requires signal transduction by Raf, but not XralB. Finally, we find that XralB is
preferentially activated in the marginal zone of Xenopus embryos, and that disruption of the
XralB pathway is most effective when targeted to this region.
6Materials and Methods
Protein extraction, electrophoretic analysis, immunoblotting and pull-down
To monitor the expression of injected mRNA, proteins were extracted from embryos and
analysed as previously described (Gusse et al., 1989). Protein extracts were separated by
SDS–PAGE on a 15% acrylamide gel and transferred to a Hybond P membrane (Amersham).
The membrane was probed overnight at 4°C with anti–rat RalB goat antibodies (Sc1531,
Santa Cruz) diluted 1/125 in 1X PBS – 1% BSA (wt/vol).  The secondary antibody,
peroxidase-linked rabbit anti-goat Ig was diluted 1/1250 (Chemicon). Signals were detected
by chemiluminescence (ECL+, Amersham).
To analyse Ral-GTP levels, protein extracts from embryos were incubated with RalBP1
agarose (Upstate Biotechnology, ref. 14-415) for 30 min. at 4° C. Immunoprecipitates were
separated on a 15% acrylamide gel and transferred to a P Hybond membrane (Amersham).
Precipitated endogenous Ral was probed with an anti-RalA antibody (Upstate Biotechnology,
ref. 20-189) diluted 1/750 in 1X PBS – 0.05% Tween -20 and 5% milk powder (wt/vol).
Signals were detected by chemiluminescence (ECL, Amersham) and quantified by
ImageQuant (Molecular Dynamics).
Embryos and microinjections
Xenopus frogs were imported from South Africa (South Africa Farms, Fish Hoek) or from the
CNRS frog colony (Rennes). Animals were housed and fed as described (Gurdon et al 1984).
Embryos were fertilized in vitro and chemically dejellied with 2% (wt/vol) cysteine-HCl, pH
7.8/7.9, then maintained in 1 X MBS (Modified Barth’s solution pH (7.6) (Gurdon and
Wickens, 1983) until microinjection. Microinjection was performed in a solution of 1 X MBS
and 3% Ficoll (wt/vol), followed by overnight incubation at 16°C in 0.1 X MBS and 3%
Ficoll, then at 15-22°C until they reached appropriate stages. Embryonic stages were
7determined according to Nieuwkoop and Faber (Nieuwkoop and Faber, 1956). In vitro
transcribed RNA (4.6 nl) was microinjected into 2-cell stage embryos in the animal
hemisphere or into 4-cell stage embryos in the marginal zone, animal pole or vegetal pole.
cDNA cloning and in vitro transcription of RNA for injection
pSP64-Ras 12V35S and 12V37G were obtained by cloning the SalI-BamHI insert
from pDCR-12V35S and 12V37G (White et al., 1996) into the SalI-BamHI sites of the pSP64
vector (Promega). pSP64-Ral-GDS was obtained by subcloning of the BamHI insert from
pCEP4-Ral-GDS (White et al., 1996). pRN3-RalBD-GST was obtained by subcloning of the
HindIII-SalI insert from pGEXT4T3-GST-RalBD (Wolthuis et al., 1998b). The 3’untranslated
regions of the pRN3 RalB clones S28N, G23V were deleted by removal of BamHI/NotI,
followed by end-filling and religation. mRNAs were transcribed from pSP64T (Promega) or
pRN3 (Lemaire et al., 1995) vectors using the SP6 or T3 mMessage mMachine (Ambion).
Confocal microscopy
Animal caps were observed using a Leica TCS-4D confocal imaging system (Leica
Instruments, Heidelberg, Germany) fitted with a 63X objective (NA 1.4). For FITC and
TRITC, an argon–krypton ion laser was used set to 488 and 568 nm, respectively. For each
optical section, double fluorescence images were acquired sequentially to avoid potential
signal contamination by linkage-specific fluorescence emission “cross-talk.” Signal noise was
reduced by line averaging of four frames. A focal series was collected for each specimen. The
focus step between sections was 1µm.
Fixation and staining of embryos with QE5 antibody and rhodamine-phalloidin
8Embryos were prepared for confocal microscopy analysis as described previously (Moreau et
al., 1999).
Animal cap assay
Animal caps were manually dissected from MBT-stage embryos. These explants were
incubated with or without FGF (100 ng/ml) in 1X MMR, 1% BSA for 4 hours at 16°C.
RNA isolation and reverse transcriptase -PCR assay
Total RNA extraction was carried out as previously described (Moreau et al 1999), except
that extracts were treated with 1 U of DNase I RQ1 (Promega)  for 30 minutes at 37° C after
the LiCl precipitation step. First strand cDNA was prepared from total RNA using the reverse
transcriptase M-MLV (Gibco-BRL, ref. 28025-013) and Oligo dT primer (Pharmacia). PCR
and analysis of cDNA was performed in 50 µl of solution containing 5µl of cDNA, 1X Taq
buffer, 3 mM MgCl2, 0.1mM (each) dNTPs, 200 ng of each specific primer, and 1 U of Taq
polymerase (Invitrogene), using the following PCR conditions: 93° C for 3 min, followed by a
variable number of cycles at 93° C for 45 s, 52° C for 50 s. and 72° C for 1 min. Ornithine
decarboxylase (ODC), Xbra, Xwnt11, Xnot, Xty2 PCR amplification was carried out for a
total of 27 cycles, and Xwnt8, Xsnail and Xcad3 amplification was for a total of 35 cycles.
The pr imer  sequences  were  as  fol lows:  ODC forward 5’  –
GTCAATGATGGAGTGTATGGATC-3’, reverse 5’- TCCATTCCGCTCTCCTGAGCAC-
3’; Xbra forward 5’ – GTGTAGTCTGTAGCAGCA-3’, reverse 5’-
GGATCGTTATCACCTCTG- 3’; Xwnt 11 forward 5’ – GTGAGAGAGGTCTGAGCTGG-
3’, reverse 5’- ACATGACATAGCAGCACC- 3’; Xnot forward 5’ –
CAGAGCAGCTGGAGAAGCTG-3’, reverse 5’- CAGTGTGATCTGAGCTGTTC- 3’; Xty2
forward 5’ – ATCTGCTCCACGACGGAC-3’, reverse 5’- GAAGAACTGCTACTTGTCC-
3’; Xcad3 forward 5’ –CAGCGCAGAACTACGTCTCC-3’, reverse 5’-
9CCCAGTCCCAGATGGATGTG- 3’; Xwnt8  forward 5’ –AGATGACGGCATTCCAGA-3’,
r e v e r s e  5 ’ -  T C T C C C G A T A T C T C A G G A -  3 ’ .
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Results
XralB is activated by FGF
Activation of Ral proteins by growth factors, including those signalling through
receptor tyrosine kinases (EGF, FGF, etc.), has been documented in a variety of contexts
(Wolthuis et al., 1998a), (Suzuki et al., 2000) (Nakashima et al., 1999). Considering the role
of FGFs in mesoderm induction, and our previous observations that XralB function is
required for gastrulation, we wished to determine whether the FGF pathway regulates XralB.
Animal cap explants were dissected at the blastula stage and cultured for 4 hours in the
presence or absence of bFGF (Fig. 1A). After incubation, mRNA was extracted to verify the
activation of the pan-mesodermal gene marker Xbra by bFGF (Fig. 1B). To determine the
relative abundance of endogenous GTP-bound XralB, protein was also extracted and analysed
by affinity purification (pull-down) using GST fused to the Ral binding domain of RalBP1
(GST-RalBP1) (Fig. 1C).  Animal caps incubated in the presence of bFGF became elongated
(Fig. 1A), and displayed an increase in Xbra transcript levels  (Fig. 1B) and GTP-bound
XralB (Fig. 1C). Thus, the Ral pathway can be activated by FGF signalling during early
Xenopus development.
Ras activates the XralB protein via Ral-GDS binding
 Ras stimulates multiple, distinct signalling cascades. Indeed, White et al (White et al.,
1995) have shown that a mutant form of Ras, Ras 12V37G, does not transform cells, but can
be complemented for transformation by another Ras mutant, Ras 12V35S. Ras 12V35S binds
specifically to Raf kinase but not to Ral-GDS, whereas Ras 12V37G only binds to Ral-GDS
(White et al., 1996).  We utilized these Ras mutants to assess the relative roles of Ras
signalling via Raf and Ral-GDS in the activation of XralB in Xenopus embryos.
Whole embryos were injected with Ras 12V35S (0.5 ng/blastomere), or Ras
12V37G (0.5 ng/blastomere) RNA at the two-cell stage, grown until the 128/256-cell stage
and protein was extracted and analysed by Ral-GTP pull-down. We found the level of
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activated XralB to be specifically increased in embryos injected with Ras 12V37G (Fig. 2).
Xral-GTP levels in embryos injected with Ras 12V35S were similar to the basal levels
observed in uninjected embryos. To confirm the specificity of XralB activation by Ras
12V37G, we asked whether a dominant-negative form of RalB, XralB S28N, can interfere
with XralB activation when co-injected with Ras 12V37G.  In such embryos, levels of XralB-
GTP are similar to those of control embryos (Fig. 2). These results indicate that Ras can
activate XralB independently of Raf kinase.
Ras can activate two independent targets
We also examined the effect of the Ras 12V35S and 12V37G mutants on development
and morphogenesis. All embryos injected with Ras 12V35S (Fig. 3A and Table 1) appeared
normal through the end of gastrulation and 37% survived to stage 32, though many displayed
developmental defects such as a shorter axis or open neural folds. Embryos injected with Ras
12V37G displayed earlier defects. Development was normal through the midblastula
transition (MBT), but then blastomeres near the injection area became necrotic, characterised
by large bleached cells (Fig. 3A), and 30.6% of embryos (n = 186) underwent developmental
arrest prior to gastrulation (stage 10.5) (Fig. 3A). More than 96.6% of Ras 12V37G-injected
embryos failed to survive beyond neurulation (Table 1) and only 1.1% reached the tadpole
stage. To investigate if Ras 12V37G had the same target as XralB, we examined whether the
expression of this Ras mutant disrupted the integrity of the actin cytoskeleton, as does the
constitutively active form of XralB, XralB G23V (Moreau et al., 1999), and we compared the
effects of Ras 12V37G on the actin cytoskeleton with those of Ras 12V35S. Apical
blastomeres from the animal hemisphere, before and after stage 8, were observed by confocal
microscopy following F-actin staining with Rhodamin-Phalloidin. Actin cytoskeleton analysis
in embryos injected with Ras 12V37G was carried out on embryos that did not display cell
necrosis.
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As expected, embryos injected with Ras 12V37G had severely disrupted cortical and
nuclear actin cytoskeletons (Fig. 3B), whereas blastomeres of embryos injected with Ras
12V35S were similar to uninjected controls. To better characterise the timing of F-actin
disruption, we performed a kinetic study (Fig. 4). We found that F-actin is intact until the
2000-cell stage (Fig. 4D) and becomes damaged near MBT (Fig. 4 F).  This timing of Ras
12V37G-induced disruption differs from that of constitutively active XralB G23V, which
induces disruptions as early as the 256-cell stage (corresponding to the technical limit of
analysis).  Nevertheless, the ability of either Ras 12V37G or XralB G23V to disrupt the actin
cytoskeleton, together with the ability of Ras 12V37G to induce activation of XralB, suggests
that Ras 12V37G  induced disruption of the cytoskeleton is mediated by XralB.  To confirm
this apparent specificity, we co-injected the dominant-negative XralB S28N mutant with Ras
12V37S at a ratio of six mRNA molecules to one. Co-injection of XralB S28N rescued early
morphological defects, as embryos had no necrotic cells (Fig. 3A) and survived longer. The
development of these embryos was blocked during gastrulation, but this was expected, as
gastrulation arrest results from injection of XralB S28N alone. We also observed partial
rescue of the cortical actin array when XralB S28N was co-injected with Ras 12V37G (Fig.
3B). We conclude that Ras signalling via XralB and independent of Raf can cause alterations
in the actin cytoskeleton as well as cell necrosis and early embryonic death.  As Raf is known
to be an essential mediator in the activation of several Xenopus mesodermal genes by Ras
(McNicol et al., 1993), our results indicate that Ras/Raf/MAPK and Ras/XralB signalling can
act on independent targets during early Xenopus.
Ral-GDS is a putative embryonic exchange factor of Xral
Having established that Ras can affect early Xenopus morphogenesis via XralB
activation, we wished to determine which molecule mediates this event.  A good candidate for
this function is Ral-GDS, a Ral-GEF-related molecule, which specifically binds to Ras GTP
and activates Ral in a Ras-dependent manner (reviewed in (Wolthuis and Bos, 1999)).  To
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evaluate the role of Ral-GDS during Xenopus embryonic development, we injected murine
Ral-GDS mRNA (1.5 ng) into each blastomere of two-cell stage embryos.  From the 64-cell
stage, depigmentation of the animal hemisphere was observed in these embryos and during
blastula stages ectodermal lesions arise, leading to arrested development at the end of blastula
stage (Fig. 5A). A lower amount of Ral-GDS mRNA (750 pg) induces hyperpigmented cells.
The same spectrum of phenotypes, including opposing effects on cell pigmentation, are seen
in response to high and low doses of the constitutively active XralB G23V (Moreau et al.,
1999). As described for XralB G23V, in embryos injected with low doses of Ral-GDS,
patches of hyperpigmentation are maintained throughout development until the tadpole stage.
At hatching, some hyperpigmented cells are often lost with the vitelline membrane. Thus, the
phenotypic consequences of either Ral-GDS or XralB G23V misexpression are
indistinguishable.
We went on to address whether, like Ras 12V37G or XralB G23V, Ral-GDS
misexpression causes disruptions to the actin cytoskeleton.  Animal blastomeres of embryos
injected with 1.5 ng of Ral-GDS indeed lose their cortical F-actin cytoskeleton (Fig. 5B). In
contrast to Ras 12V37G, Ral-GDS-induced damage is already apparent at cleavage stages, as
is also seen in XralB G23V-injected embryos (Moreau et al., 1999). To confirm that this Ral-
GDS-induced phenotype was dependent on the XralB protein, we asked whether it could be
rescued by co-injection of XralB S28N RNA. Embryos co-injected with XralB S28N and Ral-
GDS, at a ratio of seven mRNA molecules to one, displayed a fainter depigmented phenotype
(Fig. 5A). As expected, the high quantity of XralB S28N also blocked embryonic
development beyond the gastrula stage (Fig. 5A), however no early ectodermal lesions
appeared in rescued embryos and survival up to the time of the XralB S28N-induced block
was significantly enhanced. Co-injection of XralB S28N with Ral-GDS also protected
embryos against F-actin cortical disruption (Fig. 5B). In addition, coinjection of XralB S28N
rescues the hyperpigmentation phenotype arising from lower doses of injected Ral-GDS (data
not shown).  Finally, we examined the activation of the XralB by Ral-GDS, using the pull-
14
down assay to precipitate GTP-bound Xral from embryonic lysates. Embryos injected with
750 pg and 1.5 ng of Ral-GDS RNA, respectively, displayed 1.47-fold and 2.8-fold increases
in Ral-GTP levels relative to uninjected embryos (Fig. 5C). These data demonstrate that
disruption of the actin cytoskeleton and cellular depigmentation are induced by Ral-GDS, that
these events require functional XralB signalling, and that the XralB protein is activated by
Ral-GDS. The Ras pathway is therefore able to achieve morphogenetic changes during early
development through the activation of XralB via Ral-GDS.
XralB is activated in the mesodermal marginal zone during gastrulation
In Xenopus, all mesoderm and some endoderm arises from equatorially situated cells
of cleavage-stage embryos, a region known as the marginal zone.  Furthermore, large
molecules residing in- or delivered to the marginal zone cytoplasm of early-stage blastomeres
are inherited by this cell lineage. Consistent with this, mesoderm-specific gene products and
activities are often concentrated in the marginal zone.  Because the mesoderm inducer bFGF
activates XralB, and because the Ras/Raf effector, MAPK is specifically activated in the
marginal zone, we wished to assess the relative activity of XralB in this region. We divided
stage 10.5 embryos into three parts, corresponding to the animal hemisphere, marginal zone
and vegetal hemisphere (Fig. 6A). Protein was extracted from pools of 30 such explants, and
Xral-GTP levels were assessed in pull-down assays. Levels of endogenous Xral-GTP were
clearly highest in medial zone explants (Fig. 6B). To confirm this, we increased the level of
XralB in targetted zones by direct microinjection of XralB mRNA (Fig. 6C). RNA encoding
wild-type XralB (500pg/embryo) was injected into the animal hemisphere, marginal zone or
vegetal hemisphere of four cell-stage embryos.  Protein from whole embryos (n=10) at stage
10.5 was extracted and analysed in pull-down assays. The pull-down results clearly show that
the highest levels of XralB-GTP are obtained from embryos injected in the marginal zone.
This indicates that, like MAPK activation,  XralB activation is most concentrated in the
mesodermal region of Xenopus embryos.
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Loss of XralB function in presumptive mesoderm causes arrest of gastrulation
We previously reported that microinjection of XralB S28N mRNA in Xenopus
embryos causes abnormal embryonic development (Moreau et al., 1999). Developmental
alterations caused by XralB S28N were seen to vary with the XralB S28N RNA concentration
injected, and a diversity of phenotypes was even observed to arise from a fixed quantity of
microinjected RNA. In more severely affected embryos, the blastopore failed to close during
gastrulation. The least affected embryos either had incompletely closed neural tubes or were
bent dorsally at the tailbud stage.  In light of our finding that endogenous XralB activation is
concentrated in the embryonic marginal zone, we decided to assess the relative effects of
disrupting XralB signalling with ectopic XralB S28N that was targetted to different
embryonic regions.  Four-cell embryos were injected with 750 pg of XralB S28N in each
blastomere at the apical animal hemisphere, the marginal zone or the bottom of the vegetal
hemisphere.  We confirmed the location of XralB S28N using ß-galactosidase mRNA as a co-
injected tracer.  When RNA encoding XralB S28N was microinjected into animal (Fig. 7A) or
vegetal hemispheres (Fig. 7C), the majority of embryos survived gastrulation and beyond.
Respectively, only 38.1% (n = 79) and 25% (n = 45) of such embryos failed to develop
normally through the neurula stage. However, when XralB S28N was microinjected in the
marginal zone, most embryos (81%; n =153) exhibited incomplete blastopore closure (Fig.
7B) and developmental arrest between stages 10.5 and 11.5.  Histological sections of
marginal-zone-injected embryos reveal that the coinjected ß-galactosidase is expressed in
mesoderm and that arrest occurs when these labelled cells are undergoing invagination (data
not shown).  These observations support the idea that the most severe gastrulation defects
arise when XralB S28N is targetted to prospective mesoderm and further suggest that XralB
function is specifically required by mesodermal cells to achieve the morphological changes
associated with invagination.  To verify that the effect of XralB S28N during gastrulation was
not due to a specific toxicity of XralB protein in the marginal zone, wild type XralB (4 x 750
16
pg) was injected.  No developmental disturbances were observed in these control embryos
(Fig. 7E) and over 90% (n=35) developed normally to the tadpole stage.
As an independent test for an essential role of XralB activity in the marginal zone, we
examined the effect of another protein capable of disrupting Ral signalling. The Ral binding
domain (RalBD) region of the effector protein RLIP, corresponding to the amino acids 397 to
518 of RLIP76 (Wolthuis et al., 1998a), has been shown to be sufficient for direct binding to
GTP-bound Ral in vitro. This RLIP peptide fused to either the glutathion-S-transferase (GST)
protein or the myc peptide was used in injection experiments. As a control, we coinjected
embryos at the four-cell stage with either 4 x 500 pg of GST-RalBD or 4 x 300 pg of myc-
RalBD mRNAs, together with ß-galactosidase, in the apical animal hemisphere, in the vegetal
hemisphere and in the marginal zone. Whole embryos injected with ß-galactosidase, GST, or
myc-tag mRNA alone did not show any morphological changes (data not shown). However,
as observed with XralB S28N, RalBD injected in the marginal zone caused an arrest of
gastrulation (Fig. 7D) between stages 10.5 and 11.5.  In summary, these data demonstrate a
region-specific effect of titrating XralB targets (with constitutively inactivated XralB S28N)
or XralB effector sites (with RalBD). When expressed in the marginal zone, these proteins
disrupt development at the time of mesodermal cell migration, whereas expression in other
regions has much milder consequences.
XralB signalling is not required for the induction of signature mesoderm genes
In Xenopus, FGF is able to induce the conversion of prospective animal cap ectoderm
into mesoderm (Slack et al., 1987), (Kimelman and Kirschner, 1987) and FGF signalling
through the Ras pathway is required for formation of most mesoderm (Amaya et al., 1991),
(LaBonne and Whitman, 1994), (Kroll and Amaya, 1996). Induction of the expression of a
number of mesodermal genes by FGFs or Ras has been shown to depend on the MAPK and
PI3K  pathways (Whitman and Melton, 1992), (LaBonne and Whitman, 1994), (Umbhauer et
al., 1995) (Carballada et al., 2001).  We wished to assess whether or not XralB signalling is
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similarly required for the activation of these signature mesodermal genes.  Four cell-stage
embryos were injected in the animal hemisphere with mRNA encoding either XralB S28N or
Raf KD, dominant-negative constructs to disrupt Ras/XralB signalling or Ras/Raf signalling
respectively (Fabian et al., 1993). When embryos reached stage 8, animal caps were excised
and explants were cultured for 4 hours in the presence or absence of bFGF. Expression levels
of several mesodermal genes including the pan-mesodermal marker Xbra (Smith et al., 1991),
Xcad3 (Northrop and Kimelman, 1994), Xsnail (Sargent and Bennett, 1990), Xty2 (Nutt et
al., 2001) Xnot (Dassow et al., 1993), Xwnt 8 (Christian et al., 1991) and 11 (Saka et al.,
2000) were assessed by RT-PCR. Whereas the dominant-negative form of Raf inhibited
expression of all markers tested, excepted expression of Xcad3 (Fig. 8), their expression was
not significantly diminished by overexpression of XralB S28N (Fig. 8). Thus, Raf signalling,
but not XralB signalling, is essential for the induction of several key mesodermal genes by
bFGF. Considering our other data implicating XralB signalling in the control of
morphogenesis, these results suggest that mesoderm patterning and mesoderm morphogenesis
are controlled to a degree by independent pathways.
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Discussion
Ras is the upstream element of the RalB pathway
The Ral-GDS factor interacts with Ras (Hofer et al., 1994) and has been shown to be
the guanine nucleotide dissociation stimulator protein for Ral in COS cells (Urano et al.,
1996), (Kishida et al., 1997) and fibroblasts (Matsubara et al., 1999). Another small G
protein, Rap1, contains the same effector domain as Ras (Spaargaren and Bischoff, 1994).
The study of the activation of Ral in human platelets suggested that Ral-GDS could be the
effector protein of Rap1 rather than Ras (Wolthuis et al., 1998a). The potential interaction of
Ral-GDS with either activated Ras or Rap1 suggests that Ral can be activated by at least two
pathways.  However, although Rap1/Ral-GDS interaction has been seen in the two-hybrid
system and in vitro, Rap1 fails to co-immunoprecipitate with Ral-GDS in co-transfected cells,
so compartmentalization of the proteins was suggested (Nancy et al., 1999). Here we have
demonstrated that Ras activates Ral through the Ral-GDS effector in Xenopus embryos. It has
been reported that Ras recruits Ral-GDS to the plasma membrane, which can then induce the
activation of Ral in COS cells (Matsubara et al., 1999). Constitutive binding of Ral-GDS to
membranes has also been reported (Vojtek and Der, 1998).  We have confirmed these latter
data with the observation that mutation of the RalB membrane targeting sequence inhibits the
depigmentation activity of RalB G23V (data not show). It is therefore conceivable that
phenotypes arising from overexpression of wild type Ral-GDS via titration of factors
necessary for the membrane localization of endogenous Ral-GDS.
The XralB effector acts downstream of bFGF, Ras and Ral-GDS
We demonstrate that bFGF, Ras and Ral-GDS can all activate XralB.  Furthermore,
misexpression of Ral-GDS or the constitutively-active RalB G23V causes the same
phenotype.  This phenotypic identity suggests that in early Xenopus embryos, XralB is the key
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target of Ral-GDS. The phenotypes arising from Ras 12V37G misexpression, by contrast,
differ from one another as well as from the Ral-GDS/RalB G23V phenotype. The complete
mesoderm induction by bFGF is likely achieved through its activation of multiple parallel
pathways.  In addition to activating XralB, bFGF activates Raf/MAPK and PI3K via Ras. The
Ras 12V37G misexpression phenotype is qualitatively similar to the Ral-GDS/RalB G23V
phenotype, but its onset is later. This could reflect a regulatory mechanism that normally
delays Ral-GDS activity, such as late regulation of maternal Ral-GDS mRNA translation or a
derepression of its activity by a post-translational modification of the Ral-GDS protein.
Indeed, a negative regulation of Ral-GDS has been demonstrated to occur through the
phosphorylation of its catalytic domain (Rusanescu et al. 2001), and positive regulation of
Ral-GDS occurs via formation of a complex with the N-terminus of PI3-K-dependent kinase
1 (Tian et al., 2002).
Ras 12V37G and Ras 12V35S have distinct effects on development (Fig. 3 and Table
1). Ras 12V37G induces large necrotic blastomeres in the injected area and embryos undergo
developmental arrest by the end of the blastula stage, whereas embryos injected with Ras
12V35S have normal blastomeres and survive until the neurula stage. Hence, two distinct
signalling pathways are controlled by Ras. One, corresponding to Ras 12V35S, activates
mesoderm induction by the classic MAP kinase pathway and causes post-gastrulation
phenotypes. The other, corresponding to Ras 12V37G, destabilizes the actin cytoskeleton
from the MBT stage onward, followed by cell necrosis and early arrest. Consistent with this, a
Raf/MAPK-independent target of Ras has been described to induce membrane ruffling
(Joneson et al., 1996) for a review see (Ridley, 1994).
  The RalB pathway is required for early embryogenesis.
It is now clear that Ras controls several cellular functions by acting on various
downstream  pathways.  However, only the Raf/MAP kinase cascade and more recently
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Ras/PI3K signalling (Carballada et al., 2001) have been investigated in early development.
Previously, we demonstrated the involvement of the Ral protein during embryogenesis. Our
current data strongly suggests a requirement for the RalB cascade during gastrulation. We
show that expression in the marginal zone of either of two distinct inhibitors of RalB
signalling causes arrest during gastrulation. The cellular mechanisms through which the RalB
pathway participates in early development are not yet understood but our results clearly
suggest that the RalB pathway affects cell behaviour by controlling actin cytoskeleton
integrity.  The presence of a distinct blastopore groove in embryos injected with XralB S28N
indicates that gastrulation is succesfully initiated in the absence of RalB signalling.
Gastrulation defects arise later, and only when RalB signalling is disrupted in presumptive
mesoderm. Cells expressing injected RalB S28N are found in the region of involuting
mesoderm of such embryos. These blocked embryos also frequently acquire ectodermal folds
in their animal hemispheres. This could be a secondary consequence of blocked invagination.
If invagination were reduced, an excess of surface tissue that would normally invaginate or
replace invaginated tissue might be expected to arise, and constraint of this excess tissue
within a limited surface would inevitably lead to folding or lesion formation. We therefore
conclude that RalB signalling is essential for the involution of mesoderm at the blastopore lip,
in an autonomous fashion. Considering that RalB signalling can induce actin cytoskeleton
disassembly, we further propose that RalB is required to effect cytoskeletal changes that drive
or enable the cellular shape changes required for involution.
RalB and its partners, Ral-GDS and the putative effector RLIP, are not present in the
Saccharomyces cerivisae genome or in other unicellular eukaryotes (Bauer et al., 1999). This
pathway, therefore, may have a general role in the regulation of multicellular behaviour, as we
have seen for Xenopus gastrulation. Indeed, in Drosophila development, RalB has also been
implicated in the control of cell shape via regulation of the actin cytoskeleton (Sawamoto et
al., 1999a) (Sawamoto et al., 1999b) and is also required for the initiation of border cell
migration during Drosophila oogenesis (Lee et al., 1996).
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In conclusion, we propose that the RalB pathway is activated  in the marginal zone
during gastrulation and participates in the control of the dynamic equilibrium between F- and
G-actin and we further propose that this function is essential for mesoderm involution during
gastrulation. It appears, therefore, that at least three Ras-dependent pathways are required
during development including the cascade of interactions between Ras/Ral-GDS/RalB, the
Ras/Raf cascade and the Ras/PI3K cascade (Fig. 9). Whereas the Ras/Raf and Ras/PI3K
pathways regulate mesodermal gene expression, the Ras/Ral pathway are likely to act directly
on F-actin, independent of gene transcription. This last point is strongly supported by the facts
that the constitutively active RalB G23V perturbs the organisation of F-actin at cleavage
stages, well before the onset of zygotic gene transcription, and that the dominant negative
form of RalB S28N fails to inhibit expression of most mesodermal genes tested.
The idea that distinct pathways control cell behaviour and gene expression is
supported by a variety of data.  In mouse fibroblasts migration and cellular morphogenesis in
response to FGF signalling occurs independently of Ras/Raf/MAP kinase (Liu et al., 1999).
Also, cell migration during tracheal morphogenesis (Skaer, 1997) and (Ribeiro et al., 2002) or
directional migration of mesodermal cells (Gisselbrecht et al., 1996) can occur in the absence
of gene activation. We propose that the actin cytoskeleton dynamics controlling these
morphogenetic changes depends in part on RalB signalling in response to FGFs, without gene
activation.  Understanding the molecular events connecting RalB activation to modification of
the actin cytoskeleton is a key area for future research. A key player will likely be RLIP, a
putative effector of Ral, which is a modular protein containing a Rac/CDC42-GAP domain.
Activated Ral protein might recruit RLIP to the membrane where it interacts with the
Rac/CDC42 protein. Rac/CDC42 is known to control rearragments of F-actin to induce
filopodia and lamellipodia (Nodes and Hall, 1995; Tapon and Hall, 1997).  Thus activated Ral
may cause localized alterations to the actin cytoskeleton via membrane localization, and
activation of an RLIP/Rac/CDC42 cascade culminating in the conversion of F-actin to G-
actin.  In this way, Ral signalling downstream of FGF, Ras and Ral-GDS may regulate
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morphogenesis at the cellular, and ultimately multicellular, level, in a transcriptionally
independent manner.
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Figure legends
Figure 1
FGF activates the XralB protein. Animal caps explanted from post-MBT embryos were
cultured for 4 h in the presence (+) or absence (-) of 100 ng/ml bFGF (A) and analysed by
RT-PCR for Xbra expression (B) or by immunoblotting to detect the GTP form of Xral (C).
Active Ral-GTP was affinity purified from lysates of 15 animal caps (C) using the Ral-
binding domain of RalBP1, and detected with anti-Ral antibodies. The result is representative
from two separate experiments.
Figure 2
Activation of endogenous XralB by Ras 12V37G. Protein from embryos injected with 2 x
500 pg of Ras 12V35S, Ras 12V37G or Ras 12V37G in combination with 3 ng of XralB
S28N, were extracted, the Ral-GTP was immunoprecipitated with RalBD-conjugated
glutathion-sepharose, and total Ral protein in whole-embryo lysates were detected subsequent
to SDS-PAGE by immunoblotting with specific antibodies, as described in the Materials and
Methods. The signal from each Ral-GTP band from experiments was quantified by
densitometry and analysed by Image-Quant. The values express the ratio of the
immunoprecipitated Ral-GTP signal / total Ral protein signal.
Figure 3
Morphogenetic pertubations induced by the Ral-GDS binding, Raf non-binding, Ras
12V37G. Shown are phenotypic effects at the blastula (stage 8) and neural plate stages (stage
14) resulting from Ras mutant mRNA injections. A - mRNAs encoding Ras 12V35S and
12V37G (500 pg/blastomere) were injected into the animal pole of each blastomere in two-
cell embryos. The white arrow indicates patches of abnormal cells in embryos injected with
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Ras 12V37G. Embryos co-injected with Ras 12V37G and XralB S28N were developmentally
arrested during gastrulation but did not display necrotic cells. B - Analysis of the cortical actin
cytoskeleton in embryos injected with either 12V35S or 12V37G, and rescue effect of XralB
S28N on Ras 12V37G. Embryos were injected with Ras 12V35S or Ras 12V37G mRNA (500
pg/blastomere), or co-injected with Ras 12V37G (500 pg/blastomere) and XralB S28N (3
ng/blastomere), respectively. The white arrow shows the reconstituted cortical actin
cytoskeleton in embryos co-injected with Ras 12V37G and RalB S28N mRNAs. The actin
cytoskeleton of animal caps was analysed at the MBT stage. Scale bars represent 50 µm;
confocal optical sections are 1 µm.
Figure 4
Onset of Ras 12V37G induced actin disruption after the mid-blastula transition.
Embryos were injected in the animal hemisphere with Ras 12V37G mRNA (500
pg/blastomere) (B, D and F) and compared to uninjected embryos (A, C and E). Cortical actin
was analysed at the 500-cell stage (A-B), the 2000-cell stage (C-D), and the MBT (E-F).
Figure 5
Morphogenetic pertubations and XralB activation induced by Ral-GDS.
A – Phenotypic effects of Ral-GDS mRNA and rescue by the XralB S28N mutant.  Embryos
either injected with either Ral-GDS mRNA (1.5 ng/blastomere) or co-injected with XralB
S28N mRNA (4 ng/blastomere) in the animal pole of each blastomere of two-cell stage
embryos. In embryos coinjected with XralB S28N, the white arrow shows ectodermal roll
corresponding to the incomplete closure of the blastopore at the neurula stage. B –Analysis of
cortical actin cytoskeleton of embryos injected with Ral-GDS and rescue effect of XralB
S28N. Embryos were injected with Ral-GDS mRNA (1.5 ng/blastomere) alone or in
combination with XralB S28N (4 ng/blastomere each) mRNAs. The animal cap actin
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cytoskeleton was analysed after the MBT stage. The white arrow shows the reconstituted
cortical actin cytoskeleton in embryos co-injected with Ral-GDS and RalB S28N mRNAs.
Scale bars represent 50 µm and confocal optical sections are 1 µm.  C – Xral activation was
analysed by pull-down as described in the Material and Methods and Figure 2. Precipitated
Ral-GTP and total Ral protein from whole-embryo lysate were detected after immunoblotting
with specific antibodies.
Figure 6
Activation of XralB in the marginal zone of Xenopus embryos.  A and C  - Experimental
scheme showing animal cap (AN), marginal zone (MZ), endoderm (EN) and vegetative pole
(VG) domains that were dissected (A) or injected (C).  Protein from explants (B) or whole,
injected embryos (D) were extracted and analysed for RalB-GTP content by pull-down, as
described in the Material and Methods and in Figure 1.
Figure 7
Targeted disruption of RalB signalling in prospective mesoderm causes gastrulation
defects.  A - Effect of XralB S28N on early development. Embryos were coinjected  in each
blastomere of 4-cell stage embryos with XralB S28N (500 pg/blastomere), and ß-
Galactosidase (500 pg/blastomere) RNAs, in the animal apical hemisphere (A), in the
marginal zone (B) or in the bottom of the vegetal hemisphere (C). D – Effect of the Ral
binding domain of RLIP on early development. Embryos at the 4-cell stage were injected in
the marginal zone with 500 pg/blastomere of mRNA encoding the Ral binding domain of
RLIP (RalBD). These embryos remained blocked during gastrulation, even when control
embryos had reached stage 22. E – Embryos injected in the marginal zone with mRNA
encoding wild-type XralB (4 x 750 pg). The site of RNA expression was monitored by
detection of co-injected ß-Galactosidase expression. B and D show embryos corresponding to
sibling controls at stage 17. Embryos had X-gal-stained cells in the marginal zone.
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Figure 8
bFGF-induced expression of key mesoderm genes is independent of RalB signalling. RT-
PCR analysis of mRNA extracted from animal caps cultured until end of gastrulation.
Embryos at the four-cell stage were injected into the animal hemisphere of each blastomere
with either 4 x 750 pg of XralB S28N or Raf KD RNAs. Animal caps were dissected at the
midblastula stage and cultured, with bFGF (+) (100ng/ml) or without (-) bFGF, until the
siblings embryos reached the gastrulation (stage 12).
Figure 9
Ras signalling is mediated by three independent effector proteins during Xenopus
mesoderm induction and gastrulation. Ras activation leads to signalling through the
Raf/MAP kinase and PI3K pathways to activate gene expression and through the Ral-
GDS/Ral/RLIP pathway to regulate assembly and disassembly of the actin cytoskeleton in
marginal-zone-derived cells during gastrulation.
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Table I - Comparison of effects on development of both
constitutively activated form of Ras specific to Raf (Ras 12V35S) and
specific to RalGDS (Ras 12V37G).
Arrest of Development
Before
10 .5
between
10.5 to 12
between
12 to 17
between
17 to 30
Survival
After 30
Ras 12V37G 57
(30.6%)
5
(2.7%)
82
(44.1%)
40
(2.2%)
2
(1.1%)
Ras 12V35S 0 0 40
(40%)
23
(23%)
37
(37%)
Note. Each blastomere of two-cell embryos was injected with 500 pg
of mRNA.
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